Habitual Behavior and Dopamine Cell Vulnerability in Parkinson´s Disease

Habitual Behavior and Dopamine Cell Vulnerability in Parkinson´s Disease

Bibliographic Details
Main Authors:	Ledia eF. Hernandez, Peter eRedgrave, Jose eObeso
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-08-01
Series:	Frontiers in Neuroanatomy
Subjects:	Dopamine Parkinson Disease Substantia Nigra Striatum habits goal directed behavior
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnana.2015.00099/full

Similar Items

Habitual behavior and dopamine cell vulnerability in Parkinson disease
by: Ledia eF. Hernandez, et al.
Published: (2015-11-01)

Parkinson's disease: Cell Vulnerability and Disease Progression
by: Javier eBlesa, et al.
Published: (2015-09-01)

Widespread increases in malondialdehyde immunoreactivity in dopamine-rich and dopamine-poor regions of rat brain following multiple, high doses of methamphetamine.
by: Kristen Ashley eHorner, et al.
Published: (2011-05-01)

Beyond reward prediction errors: the role of dopamine in movement kinematics
by: Joseph eBarter, et al.
Published: (2015-05-01)

Interactions between the midbrain superior colliculus and the basal ganglia
by: Peter eRedgrave, et al.
Published: (2010-09-01)

Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function—Not a New Concept, but Neglected Reality
by: Michael F. Salvatore
Published: (2024-01-01)

Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter
by: Amy B. Manning-Boğ, et al.
Published: (2007-08-01)

Anterograde trans-neuronal labeling of striatal interneurons in relation to dopamine neurons in the substantia nigra pars compacta
by: Fuyuki Karube, et al.
Published: (2024-02-01)

Differential calcium dependence of axonal versus somatodendritic dopamine release, with characteristics of both in the ventral tegmental area
by: Billy T Chen, et al.
Published: (2011-06-01)

Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat
by: Alison L. McCormack, et al.
Published: (2002-07-01)

Targeted Ablation of Primary Cilia in Differentiated Dopaminergic Neurons Reduces Striatal Dopamine and Responsiveness to Metabolic Stress
by: Rasem Mustafa, et al.
Published: (2021-08-01)

Dopamine depletion in wistar rats with epilepsy
by: E. M. Trindade-Filho, et al.
Published: (2022-05-01)

Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice
by: Å. Petersén, et al.
Published: (2002-10-01)

Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease
by: Allen PF Chen, et al.
Published: (2021-06-01)

Past, present and future of the pathophysiological model of the basal ganglia
by: Jose A Obeso, et al.
Published: (2011-07-01)

Cocaine Inhibition of Nicotinic Acetylcholine ReceptorsInfluences Dopamine Release
by: Alexandra eAcevedo-Rodriguez, et al.
Published: (2014-09-01)

Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra
by: Katrina Albert, et al.
Published: (2019-06-01)

Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism
by: Timothy J. Collier, et al.
Published: (2007-04-01)

Neuronal Subset-Specific Migration and Axonal Wiring Mechanisms in the Developing Midbrain Dopamine System
by: Sara Brignani, et al.
Published: (2017-07-01)

Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease
by: Paola Imbriani, et al.
Published: (2022-10-01)

Effects of Acupuncture on Behavioral Stereotypies and Brain Dopamine System in Mice as a Model of Tourette Syndrome
by: Lixue Lin, et al.
Published: (2019-10-01)

Initial Molecular Mechanisms of the Pathogenesis of Parkinson’s Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease
by: Anna Kolacheva, et al.
Published: (2024-01-01)

Serotonergic neurons mediate ectopic release of dopamine induced by l-DOPA in a rat model of Parkinson's disease
by: Sylvia Navailles, et al.
Published: (2010-04-01)

Basal ganglia for beginners: the basic concepts you need to know and their role in movement control
by: Gabriel S. Rocha, et al.
Published: (2023-08-01)

A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease
by: Vignayanandam Ravindernath-Jayashree Muddapu, et al.
Published: (2022-04-01)

Conservation of the Direct and Indirect Pathway Dichotomy in Mouse Caudal Striatum With Uneven Distribution of Dopamine Receptor D1- and D2-Expressing Neurons
by: Kumiko Ogata, et al.
Published: (2022-02-01)

Effects of Chemogenetic Inhibition of D1 or D2 Receptor-Containing Neurons of the Substantia Nigra and Striatum in Mice With Tourette Syndrome
by: Lixue Lin, et al.
Published: (2021-12-01)

Midbrain dopaminergic neurons generate calcium and sodium currents and release dopamine in the striatum of pups
by: Diana Carolina Ferrari, et al.
Published: (2012-03-01)

Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
by: Lars eBrichta, et al.
Published: (2014-12-01)

Enhanced training protects memory against amnesia produced by concurrent inactivation of amygdala and striatum, amygdala and substantia nigra, or striatum and substantia nigra
by: Rigoberto eSalado-Castillo, et al.
Published: (2011-12-01)

Parkinson’s Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges
by: Hirohisa Watanabe, et al.
Published: (2024-02-01)

Current treatments in Parkinson's including the proposal of an innovative dopamine microimplant
by: M. Velázquez-Paniagua, et al.
Published: (2016-04-01)

Dietary and Intraperitoneal Administration of Selenium Provide Comparable Protection in the 6-Hydroxydopamine Lesion Rat Model of Parkinson's Disease
by: Cecilia M. Fox, et al.
Published: (2007-01-01)

Localization and Function of GABA Transporters GAT-1 and GAT-3 In The Basal Ganglia
by: Xiaotao eJin, et al.
Published: (2011-07-01)

Differential vulnerability of substantia nigra and corpus striatum to oxidative insult induced by reduced dietary levels of essential fatty acids
by: Henriqueta Dias Cardoso, et al.
Published: (2012-08-01)

Arbutin effectively ameliorates the symptoms of Parkinson’s disease: the role of adenosine receptors and cyclic adenosine monophosphate
by: Jie Zhao, et al.
Published: (2021-01-01)

Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance
by: Andrii eDomanskyi, et al.
Published: (2014-09-01)

Neuropathology of the Basal Ganglia in SNCA Transgenic Rat Model of Parkinson’s Disease: Involvement of Parvalbuminergic Interneurons and Glial-Derived Neurotropic Factor
by: Emanuela Paldino, et al.
Published: (2022-09-01)

Magnetic resonance imaging of the dopamine system in schizophrenia – A scoping review
by: Julia Schulz, et al.
Published: (2022-09-01)

Somatotopic organization of the primate basal ganglia
by: Atsushi eNambu
Published: (2011-04-01)